Exposure to multiwalled carbon nanotubes and allergen promotes early- and late-phase increases in airway resistance in mice

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 12, 2012, Pages 2133-2140

  Mizutani, Nobuaki ^a   Nabe, Takeshi ^b   Yoshino, Shin ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant activity; Airway resistance; Allergic asthma; Carbon nanotube; Goblet cell hyperplasia

Indexed keywords

ALLERGEN; COMPLEMENT COMPONENT C3A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MULTI WALLED NANOTUBE; OVALBUMIN;

AIRWAY RESISTANCE; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CELL HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; GOBLET CELL HYPERPLASIA; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; RISK ASSESSMENT; SENSITIZATION;

AIRWAY RESISTANCE; ALLERGENS; ALUM COMPOUNDS; ANIMALS; ASTHMA; GOBLET CELLS; HYPERPLASIA; HYPERSENSITIVITY; IMMUNOGLOBULINS; INFLAMMATION; INTERLEUKINS; LUNG; MALE; MICE; MICE, INBRED BALB C; NANOTUBES, CARBON; OVALBUMIN;

EID: 84871562162     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00357     Document Type: Article

References (43)

1. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol., 22, 789-815 (2004).
2. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med., 326, 298-304 (1992).
3. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest, 101, 916-921 (1992).
4. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat. Immunol., 3, 715-720 (2002).
5. Matsui EC, Hansel NN, McCormack MC, Rusher R, Breysse PN, Diette GB. Asthma in the inner city and the indoor environment. Immunol. Allergy Clin. North Am., 28, 665-686, x (2008).
6. Service RF. Nanotoxicology. Nanotechnology grows up. Science, 304, 1732-1734 (2004).
7. Sun YP, Fu K, Lin Y, Huang W. Functionalized carbon nanotubes: properties and applications. Acc. Chem. Res., 35, 1096-1104 (2002).
8. Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, McDonald JD. Pulmonary and systemic immune response to inhaled multi-walled carbon nanotubes. Toxicol. Sci., 100, 203-214 (2007).
9. Murr LE, Garza KM, Soto KF, Carrasco A, Powell TG, Ramirez DA, Guerrero PA, Lopez DA, Venzor J 3rd. Cytotoxicity assessment of some carbon nanotubes and related carbon nanoparticle aggregates and the implications for anthropogenic carbon nanotube aggregates in the environment. Int. J. Environ. Res. Public Health, 2, 31-42 (2005).
10. Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW, Celio M, Catsicas S, Schwaller B, Forró L. Cellular toxicity of carbon-based nanomaterials. Nano Lett., 6, 1121-1125 (2006).
11. Manna SK, Sarkar S, Barr J, Wise K, Barrera EV, Jejelowo O, Rice-Ficht AC, Ramesh GT. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett., 5, 1676-1684 (2005).
12. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J. Toxicol. Environ. Health A, 67, 87-107 (2004).
13. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol., 207, 221-231 (2005).
14. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol., 289, L698-L708 (2005).
15. Nabe T, Zindl CL, Jung YW, Stephens R, Sakamoto A, Kohno S, Atkinson TP, Chaplin DD. Induction of a late asthmatic response associated with airway inflammation in mice. Eur. J. Pharmacol., 521, 144-155 (2005).
16. Mizutani N, Nabe T, Yoshino S. Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J. Immunol., 183, 4039-4046 (2009).
17. Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, Stark WJ, Bruinink A. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol. Lett., 168, 121-131 (2007).
18. Fraczek-Szczypta A, Menaszek E, Blazewicz S. Some observations on carbon nanotubes susceptibility to cell phagocytosis. J. Nanomater., 2011, 473516/1-8 (2011).
19. Pennock BE, Cox CP, Rogers RM, Cain WA, Wells JH. A non-invasive technique for measurement of changes in specific airway resistance. J. Appl. Physiol., 46, 399-406 (1979).
20. Mizutani N, Goshima H, Nabe T, Yoshino S. Establishment and characterization of a murine model for allergic asthma using allergen-specific IgE monoclonal antibody to study pathological roles of IgE. Immunol. Lett., 141, 235-245 (2012).
21. Mizutani N, Goshima H, Nabe T, Yoshino S. Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. J. Immunol., 188, 5694-5705 (2012).
22. de Haar C, Hassing I, Bol M, Bleumink R, Pieters R. Ultrafine carbon black particles cause early airway inflammation and have adjuvant activity in a mouse allergic airway disease model. Toxicol. Sci., 87, 409-418 (2005).
23. Inoue K, Takano H, Yanagisawa R, Sakurai M, Ichinose T, Sadakane K, Yoshikawa T. Effects of nano particles on antigen-related airway inflammation in mice. Respir. Res., 6, 106 (2005).
24. de Haar C, Hassing I, Bol M, Bleumink R, Pieters R. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin. Exp. Allergy, 36, 1469-1479 (2006).
25. Inoue K, Takano H, Yanagisawa R, Koike E, Shimada A. Size effects of latex nanomaterials on lung inflammation in mice. Toxicol. Appl. Pharmacol., 234, 68-76 (2009).
26. Upham JW. The role of dendritic cells in immune regulation and allergic airway inflammation. Respirology, 8, 140-148 (2003).
27. Kato T, Tada-Oikawa S, Takahashi K, Saito K, Wang L, Nishio A, Hakamada-Taguchi R, Kawanishi S, Kuribayashi K. Endocrine disruptors that deplete glutathione levels in APC promote Th2 polarization in mice leading to the exacerbation of airway inflammation. Eur. J. Immunol., 36, 1199-1209 (2006).
28. Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol., 175, 1373-1381 (2005).
29. de Jong EC, Smits HH, Kapsenberg ML. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol., 26, 289-307 (2005).
30. Koike E, Takano H, Inoue K, Yanagisawa R, Kobayashi T. Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells. Chemosphere, 73, 371-376 (2008).
31. Koike E, Takano H, Inoue KI, Yanagisawa R, Sakurai M, Aoyagi H, Shinohara R, Kobayashi T. Pulmonary exposure to carbon black nanoparticles increases the number of antigen-presenting cells in murine lung. Int. J. Immunopathol. Pharmacol., 21, 35-42 (2008).
32. Ormstad H, Johansen BV, Gaarder PI. Airborne house dust particles and diesel exhaust particles as allergen carriers. Clin. Exp. Allergy, 28, 702-708 (1998).
33. Pope CA 3rd, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J. Air Waste Manag. Assoc., 56, 709-742 (2006).
34. Nabe T, Hosokawa F, Matsuya K, Morishita T, Ikedo A, Fujii M, Mizutani N, Yoshino S, Chaplin DD. Important role of neutrophils in the late asthmatic response in mice. Life Sci., 88, 1127-1135 (2011).
35. Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J. Immunol., 130, 1891-1895 (1983).
36. Mulligan MS, Schmid E, Beck-Schimmer B, Till GO, Friedl HP, Brauer RB, Hugli TE, Miyasaka M, Warner RL, Johnson KJ, Ward PA. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest., 98, 503-512 (1996).
37. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, Lee NA. Defining a link with asthma in mice congenitally deficient in eosinophils. Science, 305, 1773-1776 (2004).
38. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest, 101, 916-921 (1992).
39. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax, 24, 176-179 (1969).
40. Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur. Respir. J., 9, 1395-1401 (1996).
41. Rankin JA, Picarella DE, Geba GP, Temann UA, Prasad B, DiCosmo B, Tarallo A, Stripp B, Whitsett J, Flavell RA. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. U.S.A., 93, 7821-7825 (1996).
42. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest., 103, 779-788 (1999).
43. Dillard P, Wetsel RA, Drouin SM. Complement C3a regulates Muc5ac expression by airway Clara cells independently of Th2 responses. Am. J. Respir. Crit. Care Med., 175, 1250-1258 (2007).